Abstract library

15 results for "ovary".
#3006 Teratoma with Malignant Transformation: A Case Report of a Neuroendocrine Tumor That Arises from the Bronchial Mucosa in a Mature Cystic Teratoma
Introduction: Mature cystic teratoma (MCT) is the most common type of germ cell tumor in the ovary. A malignant tumor that arises in a pre-existing mature teratoma is called teratoma with malignant transformation (TMT).
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Case reports
Presenting Author: MD Anna La Salvia
#3071 Hormonal Ectopic Secretion Syndromes Associated to Neuroendocine Neoplasia
Introduction: Neuroendocrine neoplasias (NEN) are able to produce and secrete bioactive peptides and cause distinct syndromes related to their biological effects. The outcome will depend on the oncological disease as well as the hormonal syndrome
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Biomarkers
Presenting Author: MD Julieta Tkatch
#3089 Mixed Large and Small Cell Neuroendocrine Carcinoma of the Endometrium: A Case Report and Literature Review
Introduction: Neuroendocrine carcinoma (NEC) is an extremely rare subtype of endometrial cancer which is usually seen among perimenopausal or postmenopausal women. It runs an aggressive course and posts a clinical challenge due to limited treatment options available.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Case reports
Presenting Author: Dr Mary Anne Cruz
Authors: Cruz M A, Uyboco J, ...
#79 PTOV-1 overexpression in neuroendocrine tumors: a new molecular marker
Introduction: PTOV-1 (Prostate Tumor Overexpressed-1) is a novel protein encoded by 12-exon gene localized in chromosome 19q.13.3. Recently identified as an androgen-induced gene, it is involved in prostate cell proliferation and in prostate human cancer. PTOV-1 expression has been demonstrated in neuroendocrine cells of normal prostate tissue. Preliminary data indicate that PTOV-1 can be related to flotilin, integrins and other cellular factors involved in cancer progression.
Conference: 7th Annual ENETS Conference (2010)
Category: Basic
Presenting Author: MD INES DE TORRES
#158 Progression-free survival (PFS) as a primary endpoint for clinical studies in advanced neuroendocrine tumors (NETs)
Introduction: Successfully testing new antitumor agents requires primary study endpoints that are clinically important, and also provide sufficient statistical power within a timeframe and population size that is feasible for the tumor type. Using overall survival (OS) as the primary endpoint in NET studies is challenging because of the low incidence (5.25/100,000 annually), disease heterogeneity, extended survival time (Yao 2008), and confounding effects of multiple therapies. These inherent aspects of NETs make OS an extremely difficult and challenging endpoint to evaluate clinical efficacy.
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: Simron Singh
Authors: Singh S, Law C, ...
#237 Clinical Case of ACTH-secreting Thymic Carcinoma with Multiple Metastases to the Brain, Ovary and Skin
Introduction: ACTH-secreting thymic carcinoma (TC) is a rare neuroendocrine tumor which has a very aggressive course. We present a case of ACTH-producing TC in a 36-year-old woman.
Conference: 8th Annual ENETS Conference (2011)
Category: Clinical
Presenting Author: Mrs Irina Komerdus
#372 A Retrospective Analysis of Neuroendocrine Tumors (NETs) in West Azarbaijan of Iran
Introduction: NETs are most often located in the intestine and lungs but they can occur in other areas of the body. Limited data are available on epidemiology and clinical patterns of NETs in Iran.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Dr Nasim Valizadeh
#381 Ovarian Primary Neuroendocrine Tumor Combined with a Monodermal Teratoma: A Case Report
Introduction: Primary neuroendocrine tumor of ovary is an uncommon neoplasm that may be found as a solitary mass or in association with teratomas or mucinous tumors.
Conference: 9th Annual ENETS Conference (2012)
Category: Basic
Presenting Author: Shahin Nateghi
#479 Efficacy and Safety of Everolimus in Metastatic Gastroenteropancreatic Neuroendocrine Tumors
Introduction: Everolimus is a treatment option for patients with pancreatic NETs, while its use in patients with gastrointestinal NETs still remains to be defined.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Professor Maria Rosaria Ambrosio
#718 Forty-Five Years of Experience in a Single Center for Surgical Treatment of Pancreatic Insulinoma
Introduction: Insulinoma is the most common endocrine pancreatic tumor. It is mostly benign and single.
Conference: 10th Annual ENETS Conference 2013 (2013)
Category: Surgical treatment
Presenting Author: professor Claudio Pasquali